Since our inception, 

CEOs Council has been totally focused on building a strategic, disruptive Next-Gen Pharma model and healthcare value innovation practice.

CEO council 1st Round Table Group pic

From left to right: Anish Dhanarajan, Co-founder and CEO, Vici Health Sciences LLC; Pascal Borderies, VP Commercial Development and Medical Affairs, Bioxcel Therapeutics; Shane J. Schaffer, Chairman & CEO, Cingulate Therapeutics; Anil Namboodiripad, SVP, Proprietary Products, Dr.  Reddy’s Laboratories & President, Promius Pharma; William Finneran, President at Viking Healthcare Solutions, Inc; Mark Simon, Partner and Co-Founder, Torreya Investment Bank; Nancy Phelan, CEO, Adhera Therapeutics, Inc.; Dr. David Lennon, President, AveXis, a Novartis Company; Marc Valdiviezo, VP Applied Digital, Indegene, Eric C Benn, Former CEO, Taiho Oncology, Former SVP, International Operations and Business Planning, BMS 


Explore new business models and opportunities for product development and commercialization to enable longer run rate for survival, strengthen ability to develop candidates, and unlock the value of innovation for small and medium size pharma and biotech